MedTrace Logo

Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients

NCT00248053 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2012-09-20

No results posted yet for this study

Summary

The purpose of this study is to assess if curcumin, a commonly used food spice, can regress colorectal adenomatous polyps in patients with familial adenomatous polyposis, an inherited form of colorectal cancer.

Conditions

Interventions

DRUG

curcumin

curcumin 500 mg by mouth, three times a day for 9 months

Sponsors & Collaborators

Principal Investigators

  • Francis M Giardiello, M.D. · Johns Hopkins University

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2008-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00248053 on ClinicalTrials.gov